Saturday, July 11, 2026

pharma

TORAY INTERNATIONAL U.K

TORAY INTERNATIONAL U.K clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

GB HQ
2 Employees
EMA registrant Type
Company details
Status
Public
HQ
GB
Employees
2
Programs
1
Drugs
8
Patents
0
Intelligence · Clinical Programs

TORAY INTERNATIONAL U.K projects

1 ClinicalTrials.gov programs sponsored by TORAY INTERNATIONAL U.K.

TORAY INTERNATIONAL U.K has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 950P1V02

    Toray International U.K. Limited

    Bladder cancer, Cholangiocarcinoma, Colorectal Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gastric Cancer, Melanoma, Ovarian Cancer, Palpable Subcutaneous Malignant Lesions, Primary Peritoneal Cancer, Renal Cell Carcinoma, Solid Tumor

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does TORAY INTERNATIONAL U.K have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.